Answers are grounded in this paper and cite their sources.
This research demonstrates the role of T cell exhaustion in graft-vs-host-disease affecting hematological malignancies.
Description The onset of graft-vs-host-disease (GVHD) remains a major complication limiting the application of allogeneic hematopoietic stem cell transplantation (aHSCT) as a form of treatment for hematological malignancies. GVHD affects 30-60% of aHSCT patients, and accounts for 15% of deaths post-aHSCT. Following an aHSCT, recipient alloantigens provide the source of donor T cell activation. Although these interactions involving CD8+ T cells are beneficial for the anti-tumor Graft-vs-Leukemia (GVL) effect, the unwanted attack of healthy tissues (ex. liver, GI) result in GVHD. Post-aHSCT, donor alloreactive T cells undergo unyielding TCR stimulation. In cancer and chronic infections, this results in the gradual deterioration of T cell responses into the state of T cell exhaustion (TEX). A few studies have examined CD8+ TEX in GVHD, primarily in hematolymphoid compartments. However, whether CD8+ T cells differentiate into prototypic TEX, and their role in GVHD remains unclear. Our initial results of donor alloreactive CD8+ T cells post-aHSCT in several preclinical aHSCT murine models suggest a phenotype of decreased memory with increased co-expression of inhibitory markers within acute and chronic GVHD target tissues. Analyses of CD8+ T cells in clinical aHSCT samples also support our working hypothesis that persistent alloantigen stimulation drives CD8+ TEX. The elucidation of the differentiation fate of donor alloreactive CD8+ T cells post-aHSCT may enable therapeutic advances.
No takes yet. Share an insight, caveat, or question.
Gallardo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: